Century Therapeutics (IPSC) Other Operating Expenses (2020 - 2025)

Century Therapeutics (IPSC) has 5 years of Other Operating Expenses data on file, last reported at $29.3 million in Q3 2025.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $29.3 million in Q3 2025; TTM through Mar 2026 was $29.3 million, a 576.61% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 56.3% from the prior year.
• Other Operating Expenses for Q3 2025 stood at $29.3 million, up from $4.3 million in the prior quarter.
• Over the last five years, Other Operating Expenses for IPSC reached as high as $29.3 million in Q3 2025 and fell as low as $4.0 million in Q3 2023.
• Historically, Other Operating Expenses has averaged $10.8 million across 4 years, with a median of $7.2 million in 2022.
• On a YoY basis, Other Operating Expenses climbed as much as 67.08% in 2024 and fell as far as 67.08% in 2024.
• Year by year, Other Operating Expenses stood at $10.0 million in 2022, then surged by 31.45% to $13.1 million in 2023, then tumbled by 67.08% to $4.3 million in 2024, then surged by 576.61% to $29.3 million in 2025.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $29.3 million in Q3 2025, $4.3 million in Q4 2024, and $13.1 million in Q4 2023.